INVOX PHARMA LIMITED - Profile & Financials

CompanyTrack

Previous Company Names

C-LAB INTERNATIONAL LIMITED 12 Mar 2021 — 7 Jun 2021

Accounts Submitted 7 Oct 2025 Next due 30 Sept 2026 3 months remaining

Confirmation Submitted 6 Mar 2026 Next due 5 Mar 2027 8 months remaining

Net assets £-307M £155M 2024 year on year

Total assets £245M £70M 2024 year on year

Total Liabilities £552M £85M 2024 year on year

Charges None No charges registered

Contact & Details

Contact

Registered Address

Suite 2, First Floor, Westworks Wood Lane White City Place London W12 7FQ England

Telephone

0800 000 0000

[email protected]

Website

www.example.com

Full company profile for INVOX PHARMA LIMITED (13262308), an active life sciences and medical technology company based in London, England. Incorporated 12 Mar 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Period 1 Jan → 31 Dec 2024

Type full

Next accounts 31 Dec 2025

Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.08M

Increased by £736.12k (+214%)

Net Assets

-£306.99M

Decreased by £154.83M (-102%)

Total Liabilities

£552.05M

Increased by £85.20M (+18%)

Turnover

N/A

Employees

Increased by 52 (+111%)

Debt Ratio

225%

Increased by 77 (+52%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 31 Dec Year End	2023 31 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

0 active 3 resigned

Show resigned officers

						Status
No officers found

No officers found

Shareholders

Shareholders (1)


Sino Biopharmaceutical Limited	100.0%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

INVOX PHARMA LIMITED Current Company

PHION THERAPEUTICS LTD united kingdom

INVOX BELGIUM UK LTD united kingdom

Charges

No charges registered

Properties

0 total

No related properties

Documents

Company Filings

Date	Category	Description
6 Mar 2026	Confirmation Statement	Confirmation statement made on 19 Feb 2026 with no updates
11 Nov 2025	Resolution	Resolutions
7 Oct 2025	Accounts	Annual accounts made up to 31 Dec 2024
11 Mar 2025	Confirmation Statement	Confirmation statement made on 11 Mar 2025 with no updates
6 Jan 2025	Accounts	Annual accounts made up to 31 Dec 2023

6 Mar 2026 Confirmation Statement

Confirmation statement made on 19 Feb 2026 with no updates

11 Nov 2025 Resolution

Resolutions

7 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

11 Mar 2025 Confirmation Statement

Confirmation statement made on 11 Mar 2025 with no updates

6 Jan 2025 Accounts

Annual accounts made up to 31 Dec 2023

Recent Activity

Latest Activity

Confirmation statement made on 19 Feb 2026 with no updates

3 months ago on 6 Mar 2026

Resolutions

7 months ago on 11 Nov 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 7 Oct 2025

Confirmation statement made on 11 Mar 2025 with no updates

1 years ago on 11 Mar 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 6 Jan 2025